Andrew Clements, PhD, is a Senior Scientific Advisor for the Emerging Threats Division in the U.S. Agency for International Development’s Bureau for Global Health. He received his PhD in Anaerobic Microbiology from Virginia Tech and completed his post-doctoral training in biochemistry at the U.S. National Institutes of Health. Between 1997 and 2005, he served as an infectious disease advisor at USAID focusing on the development, management, and monitoring of international programs to address malaria, tuberculosis, and antimicrobial resistance and strengthen infectious disease surveillance. Since 2005, he has managed several efforts at USAID-- to include the PREDICT and PREVENT projects and partnerships with the Food and Agriculture Organization (FAO) of the U.N. and the World Health Organization (WHO)--to better understand and prevent primary spillover of emerging zoonotic pathogens in Lower- and Middle-Income Countries. He also analyzes trends for emerging zoonotic threats and has participated in USAID’s responses to emerging diseases, including H5N1 and H7N9 avian influenza, H1N1 pandemic influenza, MERS-CoV, and Ebola.